Smartphone Ballistocardiogram App

Reference number 6103

Sectors: Healthcare

Industries: Medical Devices

Cardiovascular disease (CVD) is the number one cause of death globally, according to the World Health Organisation, with an estimated 17.5 million deaths from CVD in 2012.

Smart phone Ballistocardiography (BCG) is a novel measurement method that requires fewer sensors (≥ 1) placed above the heart. It measures the physical movement of the chest due to the heart beating rather than electrical signals measured by ECG. Due to this neat mechanism, conductive gel is not required.

Proposed use

  • Ballistocardiography

Problem addressed

The current standard way to measure heart activity is electrocardiography (ECG), which measures electrical activity on the surface of the torso. Many common heart conditions affect the degree and timing of electrical activity in the heart, which is captured by the ECG signal. ECG has become the standard technique as correlations between heart conditions and features of the ECG signal are very well-established.

ECG requires the patient to have a number of electrodes applied to their torso, with a conductive gel applied between the skin and the sensor. Consequently, it is typically administrated in hospitals, though sometimes in GP surgeries as well. It is therefore normally used on a patients at risk from CVD, and is not suitable for regular, casual testing at home.

Technology overview

Developed by the research group of Dr Aldo Faisal, this app incorporates signal-processing methods that can produce a BCG signal highly similar to an ECG signal in early-stage testing. Modern smartphones typically contain accelerometers capable of measuring this movement, and this app utilises this capability, allowing a smartphone to become a portable BCG, capable of being used by anyone without requiring a trip to the GP or hospital.

The smartphone-obtained BCG has been demonstrated to detect the P wave, T wave and QRS complex and to translate that signal into an estimated ECG signal that closely overlaps with a real ECG reading.

Benefits

  • ECG-quality data from a smartphone
  • Comparable technology is already being adopted by target customers
  • Gel free
  • Applicable for home users, health suite app providers, health insurers, healthcare providers and payers

Intellectual property information

EP3096686 A1 HEART FAILURE MONITORING APP

US10285650 B2 HEART MONITORING DEVICE AND METHOD

Inventor

Portrait of Professor Aldo Faisal
Professor A. Aldo Faisal

Professor of AI & Neuroscience
Faculty of Engineering, Department of Bioengineering

Visit personal site

Contact us about this technology



Contact

Dr Marika Reay

Industry Partnerships and Commercialisation Senior Executive, Engineering

Dr Marika Reay is Industry Partnerships and Commercialisation Senior Executive for the Faculty of Engineering at Imperial College London

Contact Marika

+44 (0)20 7594 6867

m.reay@imperial.ac.uk

Related technologies

Acoustic sub-aperture processing (ASAP) for ultrasound vascular imaging

Acoustic sub-aperture processing (ASAP) for ultrasound vascular imaging

Ultrasound is one of the most commonly used clinical imaging modalities, characterized by its real-time capability, excellent safety, ... Find out more

ArterioWave – simple ultrasound-based diagnosis and monitoring of heart failure

ArterioWave – simple ultrasound-based diagnosis and monitoring of heart failure

More than 26 million people worldwide suffer from heart failure; there are around 1 million new cases annually in the US ... Find out more

Bioharmonophores for biomedical precision imaging

Bioharmonophores for biomedical precision imaging

Biodegradable, second-harmonic generating nanoprobes for targeted, high-resolution in vivo tumour imaging Find out more

Sign up for updates

Sign up for monthly technology alerts via email, and find other ways to connect with us.

Loading...